Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial.
Pradeesh SivapalanNiklas R JørgensenAlexander G MathioudakisJosefin EklöfTherese LapperreCharlotte Suppli UlrikHelle F AndreassenKarin ArmbrusterPraleene SivapalanJulie JannerNina GodtfredsenUlla M WeinreichThyge L NielsenNiels SeersholmTorgny WilckePhilipp SchuetzTobias W KlausenKristoffer MarsåJørgen VestboJens-Ulrik JensenPublished in: Respiratory research (2020)
ClinicalTrials.gov Identifier: NCT02857842 . Submitted August 2nd, 2016.
Keyphrases
- phase iii
- phase ii
- double blind
- open label
- end stage renal disease
- placebo controlled
- bone mineral density
- clinical trial
- ejection fraction
- newly diagnosed
- chronic obstructive pulmonary disease
- chronic kidney disease
- study protocol
- peritoneal dialysis
- randomized controlled trial
- patient reported outcomes
- lung function
- postmenopausal women
- patient reported